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Abstract
Background: Tumor cells in vivo encounter diverse types of microenvironments both at the site of the primary tumor and at
sites of distant metastases. Understanding how the various mechanical properties of these microenvironments affect the
biology of tumor cells during disease progression is critical in identifying molecular targets for cancer therapy.
Methodology/Principal Findings: This study uses flexible polyacrylamide gels as substrates for cell growth in conjunction
with a novel proteomic approach to identify the properties of rigidity-dependent cancer cell lines that contribute to their
differential growth on soft and rigid substrates. Compared to cells growing on more rigid/stiff substrates (.10,000 Pa), cells
on soft substrates (150–300 Pa) exhibited a longer cell cycle, due predominantly to an extension of the G1 phase of the cell
cycle, and were metabolically less active, showing decreased levels of intracellular ATP and a marked reduction in protein
synthesis. Using stable isotope labeling of amino acids in culture (SILAC) and mass spectrometry, we measured the rates of
protein synthesis of over 1200 cellular proteins under growth conditions on soft and rigid/stiff substrates. We identified
cellular proteins whose syntheses were either preferentially inhibited or preserved on soft matrices. The former category
included proteins that regulate cytoskeletal structures (e.g., tubulins) and glycolysis (e.g., phosphofructokinase-1), whereas
the latter category included proteins that regulate key metabolic pathways required for survival, e.g., nicotinamide
phosphoribosyltransferase, a regulator of the NAD salvage pathway.
Conclusions/Significance: The cellular properties of rigidity-dependent cancer cells growing on soft matrices are
reminiscent of the properties of dormant cancer cells, e.g., slow growth rate and reduced metabolism. We suggest that the
use of relatively soft gels as cell culture substrates would allow molecular pathways to be studied under conditions that
reflect the different mechanical environments encountered by cancer cells upon metastasis to distant sites.
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Introduction
Sensing the mechanical properties of the extracellular matrix
(ECM) is a central mechanism for regulating the differentiation
and proliferation of a multitude of cell types both in vitro and in vivo.
Ample evidence implicates alterations in the signaling pathways
that regulate the response of cells to microenvironmental cues as
critical events in tumor initiation, progression, metastasis and
perhaps tumor dormancy [1,2]. In addition, the increase in tissue
rigidity due to local accumulation of a dense, crosslinked collagen
matrix is a hallmark of cancer progression in soft tissues and is the
basis for detection of many types of tumors by physical palpation
[3,4].
Analysis of human cancer cell lines in cell culture is almost
always performed using cells cultured on rigid plastic, or, less
often, in Matrigel or soft agar, the mechanical properties of
which are poorly defined and/or difficult to modulate. We have
previously described a simple high-throughput method for
culturing tumor cells on biologically relevant flexible substrates
using ECM conjugated polyacrylamide (PA) gels that can span
a stiffness range encompassing elastic moduli of 100 pascals ([Pa]
or N/m2)–150,000 Pa [5]. In this assay we use a 96-well assay
system that arrays PA gels of varying stiffness in user defined
increments across the plate [6]. We have used this assay to assess
how changes in the rigidity of the ECM modulate the biological
properties of tumor cells, including growth, morphology, and
migratory properties. The cancer cell lines tested were grouped
into two categories based on their proliferation profiles: ‘‘rigidity
dependent’’ lines exhibited increasing cell growth as extracellular
rigidity increased, while ‘‘rigidity independent’’ lines grew equally
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Importantly, cells which grew poorly on soft gels exhibited
decreased spreading and migration under these conditions and
grew poorly when introduced into the soft tissue environment of
the lung. The rigidity-dependent lung carcinoma line A549
responded to culture on soft gels by expressing the differentiated
epithelial marker E-cadherin and decreasing the expression of the
mesenchymal transcription factor Slug. Similarly, rigidity has also
been found to modulate the epithelial-to-mesenchymal transition
in normal epithelial cells [7]. These observations demonstrate
that the mechanical properties of the matrix environment play
a significant role in regulating the proliferation and the
morphological properties of cancer cells, and that the ‘‘rigidity
profile’’ is an intrinsic property of each cancer cell line.
Many cancer cell lines respond to less rigid microenvironments
by proliferating more slowly; however, alterations in cellular
metabolism due to changes in the rigidity of the microenviron-
ment have not been well characterized. Cellular changes in
metabolic processes such as protein synthesis may be especially
relevant as tumor cells enter into a ‘‘dormant’’ state, primarily at
sites of distant metastases where the cells have been introduced to
a foreign microenvironment [8,9]. In this study we investigated
the properties of rigidity-dependent cancer cell lines that
contribute to their differential growth on soft and rigid poly-
acrylamide substrates. Compared to cells growing on more rigid/
stiff substrates, cells on soft substrates (150–300 Pa) exhibited
a longer cell cycle, due predominantly to an extension of the G1
phase of the cell cycle, and were metabolically less active,
showing decreased levels of intracellular ATP and a marked
reduction in protein synthesis. To identify the proteins which
exhibit differential synthesis rates when the cells are cultured on
soft versus stiff gels, we used a recently developed application of
stable isotope labeling of amino acids in culture (SILAC) and
mass spectrometry to measure the rates of protein synthesis of
over 1200 cellular proteins under conditions of growth on soft
and rigid/stiff substrates [10]. Whereas overall rates of protein
synthesis decrease markedly in rigidity-dependent cells grown on
soft substrates, we identified cellular proteins whose syntheses
were preferentially inhibited by culturing on soft substrates and
proteins whose syntheses were relatively preserved when growing
on soft matrices. The former category included proteins that
regulate cytoskeletal structures (e.g., tubulin subunits) and
glycolysis (e.g., phosphofructokinase P-1 and ATP synthase),
whereas the latter category included proteins that regulate key
metabolic pathways necessary for counteracting the damage from
reactive oxygen species, such as aldo-keto reductase family
members and nicotinamide phosphoribosyltransferase, a regulator
of the NAD salvage pathway. The cellular properties of rigidity-
dependent cancer cells growing on soft matrices are reminiscent
of the properties of dormant cancer cells, i.e., slow growth rate
and reduced metabolism. These data support the idea that the
rigidity of the microenvironment can modulate tumor cell
proliferation by modulating fundamental cellular processes.
Further, the soft plate technology may provide a unique platform
for the study of cancer cells undergoing dynamic regulation of
proliferation in response to changes in the mechanical environ-
ment, thus providing insights into how microenvironmental
changes modulate cancer cell growth in experimental animal
models and in patients.
Results
Cell cycle progression of rigidity-dependent cells on soft
gels
We have previously shown that a panel of cancer cell lines can
be segregated based upon the ability to proliferate on soft
(,1000 Pa) collagen-coated gels. A549 cells (lung carcinoma)
and MDA-MB-231 cells (breast carcinoma) are classified as
‘‘rigidity-dependent’’ and exhibit doubling times that are at least
2 fold longer on soft versus stiff matrices. In contrast, the ‘‘rigidity-
independent’’ mPanc96 cells (pancreatic carcinoma) grow equally
well on soft compared to stiff matrices and have similar doubling
times under these conditions ([5], unpublished observations).
To understand the molecular basis for the slow growth of
rigidity-dependent cancer cell lines on soft matrices, we measured
key regulators of cell cycle progression as well as the time required
for cells to transverse the cell cycle on soft or stiff substrates. Cyclin
D1 is critical for cells to enter the cell cycle, and the loss of cyclin
D1 expression is a marker for cells that have exited the cell cycle
and are quiescent [11]. Additionally, cyclin D1 expression has
been shown to be regulated by matrix rigidity through the FAK-
dependent activation of Rac in untransformed cells [12]. The
expression of cyclin D1 in rigidity-dependent cancer cells was
measured to determine whether the cells exit the cell cycle when
cultured on soft gels. Rigidity-dependent A549 or MDA-MB-231
cells were cultured on 150 Pa, 4800 Pa, or 19200 Pa gels for 2 or
5 days, and cyclin D1 expression was measured by western blot.
Both cell lines still expressed cyclin D1 even when cultured on the
soft (150 Pa) gels (Figure 1). These data indicate that rigidity-
dependent cells do not exit the cell cycle, even on soft gels where
the cells exhibit slower growth.
Since rigidity-dependent A549 cells do not exit the cell cycle
when plated on soft gels, and only ,5% of the cells undergo
apoptosis under these conditions [5], we hypothesized that these
cells are progressing through the cell cycle more slowly than when
they are growing on stiff substrates. To examine the rate of
progression through specific phases of the cell cycle, the rigidity-
dependent lung carcinoma line A549 was cultured on soft (150 Pa)
or stiff (19200 Pa) gels for two or five days and then pulsed for
30 minutes with the nucleotide analog bromodeoxyuridine (BrdU)
to label the population of cells undergoing DNA synthesis. Time
spent in each phase of the cell cycle was determined by FACS to
track the BrdU-positive population as the cells progressed through
the S and G2 phases and accumulated in the G1 phase [13]. As
shown in Figure 2, cells on soft gels progressed more slowly
through the G1 phase of the cell cycle compared to the same cells
growing on stiff matrices (Figure 2), consistent with a global
decrease in cellular metabolism or anabolic processes that affect
the cellular ‘‘growth’’ stage of the cell cycle. Because the cell cycle
profiles are similar after 2 and 5 days on soft gels, it is likely that
this represents a steady-state measurement, as opposed to the
possibility that cell growth is gradually slowing down over time.
Based on the calculated length of the cell cycle for cells growing on
soft versus stiff gels, after 5 days the ratio of cells on soft versus stiff
matrices would be 1:4.3. The same ratio of growth on soft versus
stiff gels (1:4.3) was observed by manually counting the number of
cells present at five days, thereby validating the BrdU pulse-chase
calculations.
Cellular metabolism in rigidity-dependent cells cultured
on soft gels
The G1 phase of the cell cycle relies heavily upon cellular
metabolic events and is critical for the synthesis of structural
proteins and enzymes that contribute to the generation of new
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PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e37231Figure 1. Cyclin D1 expression in rigidity-dependent cells growing on soft and stiff gels. A549 cells and MDA-MB-231 cells were cultured
on 150 Pa, 4800 Pa, or 19200 Pa polyacrylamide gels for 2 or 5 days. Cells were lysed and analyzed by western blot for the expression of cyclin D1
(top panel). The expression of GAPDH was analyzed as a loading control (bottom panel). The blot is representative of three experiments.
doi:10.1371/journal.pone.0037231.g001
Figure 2. BrdU pulse-chase of cell cycle progression. A549 cells were pulsed with BrdU for 30 minutes following growth on soft or stiff gels for
2 days. A. Labeling cells with BrDU for cell cycle analysis. Cells are pulsed with BrDU for 30 min, and the BrDU-positive population is followed over
time as it transitions through the phases of the cell cycle. B. Scatter plot histograms of BrdU-labeled cells on soft (top panel) or stiff (bottom panel)
gels, stained for DNA content (X-axis) and BrdU (Y-axis). The times indicated are the times, in hours, after the BrdU pulse. C. Cell cycle progression
analysis was performed on the scatter plot histograms from the cells grown on gels for 2 days (left) or 5 days (right).
doi:10.1371/journal.pone.0037231.g002
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of the cell cycle was prolonged in rigidity-dependent cells grown
on soft gels, we hypothesized that there may be metabolic changes
under conditions of growth of soft substrates. Culturing the
rigidity-dependent A549 or MDA-MB-231 cells on soft gels for 2
days resulted in an approximately 50% decrease in ATP levels
compared with cells growing on stiff gels (Figure 3). Like the
lengthening of the G1 phase, the lower levels of cellular ATP are
consistent with a decrease in cellular metabolism when rigidity-
dependent cells are cultured on soft gels.
Effect of rigidity on protein synthesis in cells cultured on
soft gels
Because of the prolonged G1 phase and the decrease in ATP
levels in cells cultured on soft gels, we determined whether matrix
rigidity may regulate net protein synthesis in rigidity-dependent
cells. To assess the changes in global protein synthesis, and to
identify proteins that might be differentially synthesized under soft
versus stiff conditions, we used a recently developed application of
stable isotope labeling of amino acids in cell culture (SILAC) in
conjunction with mass spectrometry [10]. Rigidity-dependent
A549 cells and rigidity-independent mPanc96 cells were grown in
SILAC media for two generations on plastic tissue culture dishes to
fully label the proteome with ‘‘heavy’’ amino acids (Figure 4A).
Cells were then plated on either soft or stiff gels and further
cultured in ‘‘heavy’’ amino acids for an additional 4 days. Cells
were then incubated for 24 hours (‘‘pulse’’) in ‘‘light’’ media
(normal tissue culture media), and cellular proteins were isolated
from each of the samples and resolved on SDS-PAGE. Proteins
present in soft and stiff samples were analyzed by taking ten gel
slices from each protein track and subjecting each to digestion with
trypsin. Net protein synthesis during the 24 hour ‘‘pulse’’ was
measured by determining the ratio of heavy to light peptides by
mass spectrometry for proteins in the soft and stiff samples. A
preliminary experiment with A549 cells cultured on plastic yielded
heavy to light ratios (H/L ratios) of peptides that were similar to
those of A549 cells cultured on stiff gels (0.624660.2326 for plastic
vs. 0.548260.1785 for stiff gels). Figure 4B shows boxplots for H/
L ratios of proteins identified for A549 and mPanc96 cells on soft
and stiff gels using SILAC. The average heavy/light ratio of
peptides in the A549 cells on soft gels was significantly higher
(p,0.05) than in the cells on stiff gels, indicating that net protein
synthesis was decreased in cells on soft gels, (i.e., fewer light amino
acids were incorporated during the pulse in cell growing on soft
substrates compared to stiff substrates). In contrast, the heavy/light
ratios of peptides in mPanc96 cells were not significantly different
between cells growing on soft or stiff gels (p.0.05) (Figure 4B).
The mass spectrometry analysis identified 631 unique proteins
in the A549 cells and 729 unique proteins in the mPanc96 cells
(Tables S1 and S2). Relative rates of synthesis (H/L ratios) for
individual proteins were then compared between cells grown in
stiff and soft conditions to determine proteins that are differentially
‘‘expressed’’ or translated. Since the distributions of H/L ratios
differed between stiff and soft experiments, H/L ratios and
estimated variability were normalized independently for A549 and
mPanc96 samples (see Methods), and we identified proteins with
significantly different H/L ratios (p,0.05) using t-tests. Figure 5
shows the scatterplots of normalized H/L ratios between samples
growth on stiff and soft substrates. Proteins that have a significantly
smaller H/L ratio (preserved synthesis) in soft compared to stiff
gels are indicated in red and proteins that have a significantly
higher H/L ratio (slower synthesis) in soft than stiff gels are
indicated in green. The dashed line indicates the expected H/L
ratio under the null hypothesis that proteins maintain the same H/
L ratio relative to the mean.
From the proteins identified by mass spectroscopy, we separated
out the proteins that exhibited significantly different H/L ratios
(p,0.05) between cells cultured on stiff and soft gels (Table S3 for
A549 cells; Table S4 for mPanc96 cells). In A549 cells, several
proteins with common biological functions clustered in the
category of slower synthesis on soft gels (Table 1). These included
proteins involved in protein synthesis such as ribosomal proteins
and elongation factors. Subunits of microtubules (tubulins) also
clustered in the category of slower synthesis on soft gels.
Interestingly, two proteins with crucial roles in ATP production
also displayed slower synthesis rates on soft gels: 6-phosphofruc-
tokinase type C (PFKP-1) and a subunit of ATP synthase. These
data suggest that when A549 cells are cultured in a soft
microenvironment, a subset of proteins - including those involved
in translation and microtubule dynamics - is synthesized more
slowly relative to the average synthesis rate than when cultured on
stiff gels.
Conversely, proteins that had higher synthesis rates than the
bulk of the cellular proteins when plated on soft gels included
members of the aldo-keto reductase family, which are involved in
protection against reactive oxygen species, and nicotinamide
phosphoribosyltransferase, which is important for maintaining
physiological levels of the nicotinamide cofactors (i.e., NADPH)
that are important for these redox reactions (Table 2). Addition-
ally, proteins with roles in endocytosis and vesicle trafficking,
specifically annexins and Rab proteins, were also found to be
conserved in A549 cells cultured on soft gels. The data in this table
suggest that when A549 cells are cultured in a soft microenviron-
ment, the synthesis of proteins that are important for the
regulation of reactive oxygen species and membrane dynamics is
preserved.
Similar to A549 cells cultured on soft gels, several ribosomal
proteins were also synthesized more slowly in mPanc96 cells that
were cultured on soft gels (Table 3). However, unlike the A549
cells, several proteins with roles in translation were also found to
have higher synthesis rates in mPanc96 cells when cultured on soft
gels (Table 4). Additionally, while the A549 cells showed proteins
involved in vesicle trafficking and oxidative stress pathways as
having preserved synthesis rates on soft gels, proteins involved in
these processes, such as coatomer subunits and superoxide
dismutase, respectively, were synthesized more slowly in mPanc96
cells cultured on soft gels (Table 3), suggesting that these processes
may be downregulated when mPanc96 cells are growing in soft
Figure 3. ATP levels in rigidity-dependent cells cultured on soft
or stiff gels. ATP levels were measured in A549 cells (left) or MDA-MB-
231 cells (right) following culture on polyacrylamide gels for 2 days.
Data represents the average of two experiments performed in triplicate
6 S.E., of cells on soft (300 Pa) or stiff (19200 Pa) gels. Total ATP levels
were normalized to cell numbers. * p,0.05.
doi:10.1371/journal.pone.0037231.g003
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volved in the regulation of cell-matrix adhesion and actin
dynamics, including the Rac family member RhoG, fascin, and
inverted formin-2, were found to have higher rates of synthesis
when mPanc96 cells are cultured on soft gels (Table 4), in addition
to two proteins (citrate synthase and malate dehydrogenase) that
have crucial roles in the citric acid cycle, an important metabolic
process for the production of ATP and amino acid precursors.
These data suggest that when the rigidity-independent cell line
mPanc96 is cultured in a soft microenvironment, there is
a decrease in the synthesis of proteins involved in vesicle trafficking
and oxidative stress pathways, while there is an increase in the
synthesis of proteins involved in actin dynamics and the citric acid
cycle.
Because these data reflect only the synthesis of the proteins, and
the overall levels of the proteins are determined by the balance of
synthesis and degradation, we sought to test whether this alteration
of protein synthesis was actually affecting the cellular levels of these
proteins. Lysates from A549 and mPanc96 cells cultured on soft or
stiff gels were subjected to western blot for actin, a protein that had
showed no significant changes in relative synthesis when cultured
on soft gels, and two proteins that showed high sensitivity to
rigidity, namely, tubulin and phosphofructokinase-1. The levels of
the proteins were normalized to GAPDH as a loading control,
because there was not a significant difference in the relative
synthesis of GAPDH between soft and stiff gels (p=0.55, see Table
S1, line 275). As shown in Figure 6, actin was expressed at similar
levels when cultured on soft or stiff gels, while the levels of tubulin
and PFKP-1 were lower on the soft gels in A549 cells, suggesting
that the lower rate of synthesis of these proteins observed in the
SILAC data is reflected by lower levels of these proteins in cells. In
contrast, mPanc96 cells showed no changes in tubulin or PFKP-1
levels when cultured on soft gels. These data indicate that, at least
for the proteins examined (tubulin and PFKP-1), a slower rate of
synthesis corresponds to lower levels of cellular protein.
Discussion
In this paper, we demonstrate that the rigidity of the
extracellular matrix regulates cellular metabolism and protein
Figure 4. Protein synthesis is decreased in rigidity-dependent cells cultured on soft gels. A549 cells were subjected to SILAC analysis to
determine rates of protein synthesis on soft or stiff gels. A. Overview of the SILAC procedure. A549 cells were cultured on soft or stiff gels for 4 days in
the presence of ‘‘heavy’’ media, followed by a 24-hour incubation with ‘‘light’’ media. The cells were lysed, cellular proteins were digested with
trypsin, and the resulting peptides were analyzed by mass spectrometry. B. Boxplots of heavy to light (H/L) ratios of proteins from A549 cells (left) or
mPanc96 cells (right) grown on stiff (19200 Pa) or soft (150 Pa) substrates. H/L ratio distributions are significantly different between stiff and soft for
A549 cells but not for mPanc96 cells using two-tailed unpaired t-tests. The boxes contain the data between the 25 and 75 percentile, and the line
within the box indicates the median. The dashed line at the top of the graph marks the upper limit, above which the outliers were truncated.
doi:10.1371/journal.pone.0037231.g004
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A549 and MDA-MB-231 sustain the expression of cyclin D1 when
cultured in serum on polyacrylamide gels that have mechanical
properties similar to that of soft tissue such as lung or breast. In
spite of cyclin D1 expression, A549 cells, when cultured on soft
gels, show a lengthening of the G1 phase of the cell cycle,
suggesting that there may be defects in the synthesis of the
structural and enzymatic components necessary for the transition
Figure 5. Identification of proteins that are differentially regulated by rigidity. H/L ratios of proteins identified in both stiff and soft
samples plotted against each other for A549 cells (left) and mPanc96 cells (right). H/L ratios from Figure 4 were quantile normalized and t-tests were
performed using estimated variability (see Methods) to identify individual proteins with relatively different synthesis rates between stiff and soft
samples. Proteins that are synthesized faster (relatively lower H/L ratio and p-value,0.05) in soft samples (compared to stiff samples) are shown in
red, and proteins that are synthesized slower in soft samples are shown in green.
doi:10.1371/journal.pone.0037231.g005
Table 1. Proteins in A549 cells identified by mass spectrometry whose syntheses are most sensitive to changes in rigidity.
Category Protein H/L Difference P value
Protein Synthesis 39S ribosomal protein L19, mitochondrial 20.84825 4.92E-06
60S ribosomal protein L3 isoform b 20.83025 0.001151
Isoform Cytoplasmic of Lysyl-tRNA synthetase 20.69964 7.34E-05
Elongation factor 1-gamma 20.46961 4.31E-05
Asparaginyl-tRNA synthetase, cytoplasmic 20.45776 0.008219
Eukaryotic translation initiation factor 2 subunit 1 20.39179 0.009855
Elongation factor 2 20.24762 0.035289
Elongation factor 1-beta 20.24342 0.039255
cDNA FLJ55750, highly similar to Eukaryotic translation initiation factor 3 subunit 8 20.17977 0.024772
Eukaryotic translation initiation factor 6 20.15971 0.027737
Microtubules cDNA FLJ32385 fis, clone SKMUS1000110, highly similar to Tubulin alpha-8 chain 20.3963 0.003499
Tubulin beta-3 chain 20.29527 0.012761
Tubulin beta-2A chain 20.27029 2.36E-05
cDNA FLJ58687, highly similar to Tubulin alpha-4 chain 20.26169 0.049913
Tubulin, beta 20.23846 0.009491
cDNA FLJ53012, highly similar to Tubulin beta-7 chain 20.12995 0.001608
ATP Production ATP synthase subunit beta, mitochondrial 21.05954 5.18E-06
6-phosphofructokinase type C 20.88302 2.44E-05
The table lists proteins that exhibited higher heavy/light ratios (and therefore, lower synthesis) on soft gels compared to the mean.
doi:10.1371/journal.pone.0037231.t001
Matrix Rigidity Regulates Cancer Cell Metabolism
PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e37231into S phase. Accordingly, the rigidity-dependent cell lines show
lower levels of cellular ATP levels when cultured on soft gels.
Additionally, protein synthesis in A549 cells is slower under this
condition, with the synthesis of specific structural proteins and
glycolytic enzymes such as tubulin, phosphofructokinase, and ATP
synthase especially sensitive to the decrease in extracellular
rigidity. Proteins that were less sensitive to the change in rigidity
included enzymes such as aldo-keto reductase and nicotinamide
phosphoribosyltransferase that are involved in the metabolism of
ROS products.
Matrix rigidity has been suggested to be a mechanism un-
derlying the tissue tropism of cancer metastases, because growth of
carcinoma cell lines on soft or stiff gels correlates with their ability
to grow in soft or stiff tissues [5,14]. However, the mechanism(s)
that regulate the growth of cancer cells in a tissue-specific manner
are undoubtedly complicated. Our observations suggest that one
way in which rigidity-dependent cancer cells may respond to a less
than favorable tissue-matrix environment is to decrease their
metabolic state, which offers one potential mechanism for the
observed tissue tropism of tumor cells, and perhaps tissue-
dependent tumor dormancy.
Table 2. Proteins in A549 cells identified by mass spectrometry whose syntheses are least sensitive to changes in rigidity.
Category Protein H/L Difference P value
Antioxidants Aldo-keto reductase family 1 member C1 1.119452 5.86E-11
Aldo-keto reductase family 1 member B10 0.830564 1.77E-06
Aldo-keto reductase family 1 member C2 0.691516 1.66E-05
Aldo-keto reductase family 1 member C3 0.458775 0.004641
Epoxide hydrolase 1 0.321919 0.001640
Aldehyde dehydrogenase, dimeric NADP-preferring 0.267702 0.027041
Peroxiredoxin-4 0.23855 0.036688
Vesicle Trafficking Ras-related protein Rab-27B 0.637138 6.96E-07
Annexin A3 0.399658 0.013510
annexin A4 0.317661 0.014001
Annexin A1 0.267954 0.012983
Ras-related protein Rab-5C 0.25913 0.017720
Ras-related protein Rab-21 0.187404 0.011429
NAD Production Nicotinamide phosphoribosyltransferase 0.767791 3.72E-08
Kynureninase 0.294088 0.000371
The table lists proteins that exhibited lower heavy/light ratios (and therefore, higher net synthesis) on soft gels compared to the mean.
doi:10.1371/journal.pone.0037231.t002
Table 3. Proteins in mPanc96 cells identified by mass spectrometry whose rates of syntheses decrease when cultured on soft gels.
Category Protein H/L Difference P value
Protein Synthesis 60S ribosomal protein L3 isoform b 20.50342 0.003728
40S ribosomal protein S17 20.42207 0.006099
40S ribosomal protein S10 20.35175 0.008133
cDNA FLJ35809 fis, clone TESTI2006016, highly similar to Eukaryotic translation initiation factor 3
subunit 3
20.29715 0.019452
40S ribosomal protein S4, X isoform 20.2837 0.028561
60S acidic ribosomal protein P0 20.26139 0.019264
60S ribosomal protein L13a 20.22628 0.043236
Isoform Complexed of Arginyl-tRNA synthetase, cytoplasmic 20.18043 0.013539
Vesicle Trafficking Coatomer subunit zeta-1 20.5522 0.008988
Isoform 1 of Coatomer subunit alpha 20.52696 0.011334
Vesicle-trafficking protein SEC22b 20.46288 0.004961
Cytoplasmic dynein 1 heavy chain 1 20.23752 0.031111
Antioxidants Glutathion reductase delta8+9 alternative splicing variant 20.81552 9.61E-05
Peroxiredoxin-1 20.3869 0.000954
Superoxide dismutase [Cu-Zn] 20.10054 0.033937
The table lists proteins that exhibited higher heavy/light ratios (and therefore, lower synthesis) on soft gels compared to the mean.
doi:10.1371/journal.pone.0037231.t003
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Category Protein H/L Difference P value
Protein Synthesis Translational activator GCN1 0.326805 0.014649
40S ribosomal protein S5 0.247387 0.026861
IARS protein 0.10338 0.001431
Actin Dynamics Rho-related GTP-binding protein RhoG 0.269265 0.001418
Fascin 0.239673 0.020165
Isoform 2 of Inverted formin-2 0.201525 0.027210
Isoform 1 of Myosin-14 0.176649 0.032630
Citric Acid Cycle Citrate synthase, mitochondrial 0.455628 8.05E-05
Malate dehydrogenase, mitochondrial 0.313488 0.028990
The table lists proteins that exhibited lower heavy/light ratios (and therefore, higher net synthesis) on soft gels compared to the mean.
doi:10.1371/journal.pone.0037231.t004
Figure 6. Cellular levels of proteins identified by mass spectrometry. A. The levels of actin, tubulin, and phosphofructokinase-1 in A549 cells
cultured on soft (150 Pa) or stiff (19200 Pa) gels were analyzed by western blot. Bottom panels show levels of GAPDH as a loading control. B. The
levels of actin, tubulin, and PFKP-1 in mPanc96 cells cultured on soft or stiff gels as analyzed by western blot. Bottom panels show levels of GAPDH in
cell lysates as a loading control. C. Quantitation of western blot results in (A) and (B). The levels of each protein were normalized to the amount of
GAPDH in each sample. The levels of protein in samples prepared from stiff gels were set to 100%, and the levels of protein in the soft samples are
displayed as percentage expression of these samples. Results show the mean 6 S.E. of at least three experiments. * p,0.05 when compared to the
level of actin expression.
doi:10.1371/journal.pone.0037231.g006
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which residual disease is present but is asymptomatic [15].
Dormant cancer cells can reside undetected at sites distant from
the primary tumor, pending subsequent growth and clinical
recurrence [16]. Recent studies support a model whereby cancer
cells from the primary tumor will disseminate early during disease
progression, so that by the time the primary tumor is detected,
there may be dormant cancer cells already residing at distant sites
[17]. These cells are either temporarily nonproliferative, or there is
a balance between proliferation and cell death, or the immune
system is keeping the cell numbers in check. Interestingly the latter
possibility has come under scrutiny because of studies showing
a lack of tumor recurrence in cancer patients that have undergone
immunosuppressive therapy [18].
Recent studies have implicated the microenvironment as a key
regulator of tumor cell dormancy and recurrence. Specifically, the
properties of the extracellular matrix at sites of metastasis may play
important roles in determining the state of disseminated tumor
cells [9]. However, mechanistic insight as to how dormancy occurs
is scarce, since dormant cancer cells are difficult to detect and
study in vivo, and there is a paucity of in vitro models for tumor
cell dormancy. Until recently, such models have been limited to
cells grown on chorioallantoic membranes (CAMs) or on 3D
matrix derived from the Engelbreth-Holm-Swarm tumor (EHS
matrix, or Matrigel) [19,20]. Matrigel is a mixture of laminin,
collagen IV, and nidogen, in addition to a variety of proteases and
growth factors such as TGFb, FGF, EGF, PDGF, and IGF [21].
Because it is generated from a tumor, the specific composition of
Matrigel is not well defined, and it may vary from batch to batch,
producing variability in experimental results [22]. While the
mechanical properties of Matrigel have been analyzed, they also
are subject to variability because its polymerization is affected by
its composition and other experimental factors such as tempera-
ture [23]. In addition, currently the only way to alter the
mechanical properties of Matrigel is to add additional matrix
components such as collagen I [24], which may also complicate
the interpretation of experimental results.
Recently, in vitro models for tumor dormancy have expanded
to include the use of polyacrylamide gels as growth substrates [25].
Unlike Matrigel, polyacrylamide is a stable, homogeneous poly-
mer, and its mechanical properties are not sensitive to changes in
temperature [26]. Its rigidity is easily tunable by modulating the
amount of bis crosslinker without affecting its ability to bind ECM
molecules to its surface [6]. Polyacrylamide hydrogels can
encompass a spectrum of elastic moduli that includes a range of
human tissues from fat to skeletal muscle [27], and a variety of
ECM molecules can be conjugated to its surface, including
collagen, fibronectin, and unpolymerized Matrigel. In addition,
a high-throughput system was recently developed to enable the
screening of small molecule inhibitors with cells cultured on
polyacrylamide gels spanning a range of elastic moduli [5,6]. In
this study, we have used polyacrylamide gels to mimic the
mechanical properties of the soft tissue that cancer cells commonly
encounter during metastasis, such as the lung, liver, and bone
marrow.
We have shown that the growth of certain cancer cell lines slows
when cultured on soft gels [5]. In this study, we provide evidence
that cellular metabolic events are key regulators promoting the
slow growth of rigidity-dependent cells on soft matrices. Little is
known about the regulation of cellular metabolism by cell
adhesion to the extracellular matrix. Recent evidence shows that
in some cancer cells, autophagy is linked to metabolic changes
[28]. However we observed no changes in autophagy in cells
cultured on soft gels as measured by the conversion of the
autophagocytic marker LC3-I to LC3-II (data not shown). In
addition, a comparison of the gene expression profiles of 559 genes
encoding proteins in the SILAC data set from A549 cells cultured
on soft and stiff gels showed no correlation between changes in
protein synthesis and mRNA levels (data not shown). These data
are in agreement with early studies conducted by Penman and
colleagues in which they showed that fibroblasts in suspension
exhibited a decrease in protein synthesis that was rapidly
recovered when the cells were re-plated onto plastic and that
these changes were unrelated to changes in mRNA synthesis.
[29,30,31]. The mechanism(s) that leads to the halt in protein
synthesis is unclear; however, it is interesting to note that several
ribosomal proteins and elongation factors are synthesized slower
when A549 cells are cultured on soft gels. It is also interesting that
several of the proteins that are sensitive to changes in rigidity are
proteins involved in the generation of ATP – a process that
determines the metabolic state of the cell and could affect protein
synthesis. One of these proteins, phosphofructokinase P-1 (PFKP1,
or 6-phosphofructokinase type C) is a key regulator of glucose
metabolism by catalyzing the first ‘‘committed’’ step in glycolysis,
the conversion of fructose 6-phosphate to fructose 1,6-biphosphate
[32–33]. Levels of phosphofructokinase have been shown to be
regulated by insulin and nutrients [34], and its levels are decreased
in a rat model of diabetes [35], suggesting that it is an important
regulatory point in glucose metabolism. This function is in
agreement with our observation that ATP levels are lower in cells
cultured on soft gels, although it remains to be seen as to whether
these two events are causally linked.
It is also interesting to note that the synthesis of other metabolic
enzymes such as aldo-keto reductase and nicotinamide phosphor-
ibosyltransferase (Nampt) are maintained when A549 cells are
moved from stiff to soft environments. Aldo-keto reductase is
involved in the detoxification of ROS products and xenobiotic
molecules [36], which could be critical for the survival of cancer
cells, perhaps even in a ‘‘dormant’’ state, due to the high levels of
ROS produced by cancer cells [37,38]. Nampt is the rate-limiting
step in the salvage pathway to generate NAD from nicotinamide
[39], which is important for production of NADPH, an important
cofactor for aldo-keto reductases and other reactions that play vital
roles in the protection of cells from the toxicity of ROS. Therefore,
the conservation of proteins such as aldo-keto reductase and
Nampt in cells cultured on soft gels suggests that these proteins
may be critical for survival even in soft microenvironments where
the cells are proliferating more slowly. This property is in line with
recent studies demonstrating that targeting enzymes critical for
protection against oxidative stress has therapeutic potential [40].
In summary, our observations are consistent with a ‘‘slowing
down’’ in the growth and metabolism of cancer cells as they move
from a stiff to a soft environment. Future studies will be necessary
to determine if these metabolic changes occur in vivo when cancer
cells are placed in soft tissues to mimic the dissemination of the
disease.
Materials and Methods
Cell lines and antibodies
The lung cancer cell line A549, the breast cancer cell line
MDA-MB-231, and the pancreatic cancer cell line mPanc96 were
obtained from the ATCC. All cells were routinely cultured in
RPMI supplemented with 10% fetal bovine serum (FBS) and
penicillin/streptomycin. Antibodies to cyclin D1 and phospho-
fructokinase-1 were purchased from Abcam, the actin antibody
was purchased from Sigma, and the FITC-BrdU antibody was
from Invitrogen.
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Flexible polyacrylamide substrates were generated on glass
coverslips and adapted for cell culture using the method of Pelham
and Wang [24]. Polyacrylamide gels contained 3% (150 Pa) or 7%
acrylamide (4800 and 19200 Pa), and 0.04% (150 Pa), 0.05%
(4800 Pa), or 0.24% (19200 Pa) bisacrylamide. The gels were
polymerized on acid-washed, silanated, and glutaraldehyde-
treated 22 mm glass coverslips. Each gel was placed in a well of
a 6-well dish and activated using the heterobifunctional crosslinker
sulfosuccinimidyl-6(49-azido-29-nitrophenylamino) hexanoate
(Sulfo-SANPAH) followed by coating with collagen I (10 mg/ml)
for four hours at room temperature or overnight at 4uC. The gels
were soaked in the appropriate growth media at 37uC for at least
20 minutes prior to the addition of cells. Polyacrylamide coated
96-well plates were fabricated and prepared for cell culture as
previously described [6].
Cell cycle analysis
A549 cells were cultured on 150 Pa or 19200 Pa gels for 3 or 5
days. BrdU was added to the cells for 30 minutes; cells were
washed twice with PBS and incubated for 2–10 hours in fresh
growth media. Labeled cells were collected by trypsinization,
washed twice with PBS, and resuspended in 0.5 ml PBS. The cells
were fixed overnight in 4 ml of 70% ethanol. The fixed cells were
collected by centrifugation, and rehydrated in 5 ml PBS for
10 minutes. The cells were again collected by centrifugation and
DNA was denatured for 30 minutes in 0.3 ml of a solution of
0.2 mg/ml pepsin in 2M hydrochloric acid. Following denatur-
ation, the acid was neutralized with 1 ml of a solution of 3.8%
sodium tetraborate (pH 8.5). The cells were then washed once
with 1 ml of FACS buffer (2% BSA, 0.1% Triton-X 100, 0.1%
sodium azide in PBS) and incubated with anti-BrdU antibody
(diluted 1:8 in FACS buffer) for 1 hour at room temperature. The
cells were washed once with FACS buffer and resuspended in PI
staining solution (0.1% Triton X 100, 0.1% RNAase cocktail
[Ambion], 0.02 mg/ml PI in PBS). The stained cells were
analyzed by flow cytometry on a BD FACSCalibur Benchtop
Analyzer. Scatter charts were analyzed with FlowJo v8.8.6. The
length of the S phase, G2+M phase, and the potential doubling
time were calculated by measuring the percentage of the BrDU-
positive population in each phase for each timepoint, and the
length of the G1 phase was determined by subtracting the lengths
of the S and G2+M phases from the potential doubling time, as
previously described [13].
ATP assay
A549 or MDA-MB-231 cells were cultured in 96-well plates on
polyacrylamide gels with an elastic modulus range of 300 Pa
(‘‘soft’’) to 19200 Pa (‘‘stiff’’) for two days. The cells were lysed, and
cellular ATP levels were measured using the ATPlite assay (Perkin
Elmer), as per the manufacturer’s instructions. The number of cells
in each modulus was determined by using the CyQuant cell
proliferation assay on cells in parallel wells, and the cellular ATP
was normalized to cell number for each condition.
Western Blotting of lysates from cells on gels
Western blotting was performed by directly lysing the cells on the
gels with sample buffer and scraping the gels from the coverslips,
followed by removal of the gel from the lysates by centrifugation
through glass wool as previously described [5]. The proteins in the
lysates were separated by SDS-PAGE and transferred to a nitrocel-
lulosemembrane.Equalamountsofproteinwereconfirmedineach
lane on the gel by Ponceau staining.
SILAC of A549 and MPanc96 cells
A549 or mPanc96 cells were grown for two passages in SILAC
media (Lysine and Arginine replaced withLys 13C6 and Arg 13C6,
respectively) to incorporate the heavy isotopes into the cellular
proteins.Thelabeledcellswerethenculturedonsoft(150 Pa)orstiff
(19200 Pa) gels for 4 days In the presence of heavy amino acids. On
thefourthday,thecellswerewashedtwiceinPBS,andincubatedfor
24 hours in unlabeled (‘‘light’’) media. The cells were then collected
by trypsinization, counted, and lysed in sample buffer. Lysates were
separated by SDS-PAGE, and protein bands were cut from the gel
anddigestedwithtrypsin.Theresultingpeptideswereanalyzedand
identifiedbymassspectrometry[41],andforeachindividualprotein
the number of heavy (H) or light (L) peptides was determined. H/L
ratios and variability percentages for each protein were averaged
andweightedbyspectralareaacross10proteinbands.Sinceoverall
distributions of H/L ratios may differ between samples similar to
mRNA expression arrays, all protein H/L ratios identified in both
stiff and soft were normalized using quantile normalization in
MATLAB (Mathworks). Welch’s t-tests were performed to de-
termine significant differences between proteins in samples grown
on stiff and soft substrates using: average H/L ratio (quantile
normalized), variance (based on mass spec called variability
percentage), and estimated degrees of freedom (using log2 of total
spectral area as an estimated number of samples, see Tables S1 and
S2 for full list of variables). Proteins that were identified as
statistically significant are summarized in Tables S3 and S4, with
differences between stiff and soft H/L ratios, and p-values from
Welch’s t-tests.
Statistical Analysis
Unless otherwise noted, data are expressed as the mean 6 S.E.,
and p-values were calculated using unpaired Student’s t-test. Data
with p-values,0.05 were determined to be statistically significant.
Supporting Information
Table S1 List of proteins in A549 cells identified by
mass spectrometry. Data show the IPI (International Protein
Index) number, the H/L (heavy/light) ratio, the H/L variance,
and the log2 spectral area for each protein, before and after
quantile normalization. Additionally, the differences in H/L ratios
from cells on stiff gels and cells on soft gels following quantile
normalization are listed.
(XLS)
Table S2 List of proteins in mPanc96 cells identified by
mass spectrometry. Data show the IPI (International Protein
Index) number, the H/L (heavy/light) ratio, the H/L variance,
and the log2 spectral area for each protein, before and after
quantile normalization. Additionally, the differences in H/L ratios
from cells on stiff gels and cells on soft gels following quantile
normalization are listed.
(XLS)
Table S3 List of proteins in A549 cells with statistically
significant (p,0.05) differences in H/L ratios following
quantile normalization.
(XLS)
Table S4 List of proteins in mPanc96 cells with
statistically significant (p,0.05) differences in H/L
ratios following quantile normalization.
(XLS)
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